Company intelligence / Profile preview

CashWalk

Ownership: Private
Development stage: Other

Overview

CashWalk is a commercially available mobile application that incentivizes users to walk more by providing monetary rewards for step counts. The app has demonstrated strong user engagement and international expansion, with monetization strategies including advertising partnerships. No clinical trial data is reported; the product is positioned as a wellness tool rather than a regulated therapeutic.

Therapeutic areas: Endocrinology
Modalities: Non-pharmacological therapy (digital health intervention via mobile app)
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Vungle (ad monetization partner)Various advertising partners via Vungle network

Beyond the preview

Go deeper on CashWalk.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CashWalk.

Explore the full profile